Cargando…
Attention for sex in COVID-19 trials: a review of regulatory dossiers
An under-representation of women and a lack of sex-specific analyses in COVID-19 trials has been suggested. However, the higher number of men than women who are severely affected by COVID-19 and the restricted information in scientific publications may have biased these suggestions. Therefore, we ev...
Autores principales: | de Vries, Sieta T, Starokozhko, Viktoriia, Schellens, Ingrid M M, Wijnans, Leonoor, Enzmann, Harald, Cavaleri, Marco, Mol, Peter G M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935005/ https://www.ncbi.nlm.nih.gov/pubmed/35304352 http://dx.doi.org/10.1136/bmjgh-2021-008173 |
Ejemplares similares
-
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021) -
Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022) -
A review of the changes to the licensing of influenza vaccines in Europe
por: Wijnans, Leonoor, et al.
Publicado: (2015) -
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020
por: Bakker, Elisabeth, et al.
Publicado: (2023) -
Dosfilos, dossier /
Publicado: (1989)